Three recent papers show the potential benefits of several hundred new organoids, spheroids, and other cancer models. One study demonstrates that more than 600 of the models mirror their parent tumors. A second study uses organoids to uncover new cancer dependencies, or essential genes, in 147 organoids from 10 cancer types. The third study also identifies new cancer dependencies and shows that organoids from individual patients might lead to new treatment choices.